Hepatotoxicity and anti-tubercular therapy

Affiliations

Comment

Gisela Riedel M. Rev Chilena Infectol. 2010 Apr.

. 2010 Apr;27(2):176-7.

¹ Unidad de Infectología, Hospital Guillermo Grant Benavente, Facultad de Medicina, Universidad de Concepción.

No abstract available

Comment on

Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, Sreenivas V, Singh S. Sharma SK, et al. Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576. Clin Infect Dis. 2010. PMID: 20156055 Clinical Trial.

Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis.
Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Bansal R, et al. Am J Ophthalmol. 2008 Nov;146(5):772-9. doi: 10.1016/j.ajo.2008.06.011. Epub 2008 Aug 16. Am J Ophthalmol. 2008. PMID: 18708180
Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics.
Ahn HC, Yang JH, Lee HB, Rhee YK, Lee YC. Ahn HC, et al. Int J Tuberc Lung Dis. 2000 Aug;4(8):784-7. Int J Tuberc Lung Dis. 2000. PMID: 10949332
[Biological side-effects of potential anti-tubercular agents. XIV. Relation between the chemical structure, antitubercular activity and hepatotoxicity of 2-alkylthio-6-(2-chlorobenzamido) benzothiazoles].
Waisser K, Dolezal M, Sidóová E, Odlerová Z, Drsata J. Waisser K, et al. Cesk Farm. 1988 Dec;37(10):437-9. Cesk Farm. 1988. PMID: 3149912 Czech. No abstract available.
Tubercular epidural abscess in children: report of two cases.
Kumar A, Singh AK, Badole CM, Patond KR. Kumar A, et al. Indian J Tuberc. 2009 Oct;56(4):217-9. Indian J Tuberc. 2009. PMID: 20469734
Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review.
Bruno R, Sacchi P, Maiocchi L, Patruno S, Filice G. Bruno R, et al. Dig Liver Dis. 2006 Jun;38(6):363-73. doi: 10.1016/j.dld.2006.01.020. Epub 2006 May 2. Dig Liver Dis. 2006. PMID: 16631422 Review.